Geneva, March 20 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000060707) titled 'The effects of lactic acid bacteria ingestion on inflammation-related serum markers' on Feb. 26.
Study Type: Interventional
Study Design:
Single arm Non-randomized
Primary Sponsor: Meiji Co., Ltd.
Condition:
Healthy adults
Intervention:
Ingestion of lactic acid bacteria powder
Recruitment Status: Not Recruiting
Phase: Not selected
Date of First Enrollment: 2026/02/26
Target Sample Size: 11
Countries of Recruitment:
Japan
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069450
Published by HT Digital Content Services with permission from Health Daily D...